Could soon drug for multiple sclerosis in tablets

There were high hopes in patients remitting multiple sclerosis after a clinical trial of a new drug against the disease, which is offered in the form of tablets, the researchers reported. From the words of scientists, a new drug for reducing the signs of relapsing forms of multiple sclerosis and patients must accept with secondary progressive form of MS. Experts believe that the oral drug could significantly help people with this disease, as existing drugs for multiple sclerosis must be administered intravenously, which their reception is not always possible. The study was published in the journal Lancet. Multiple sclerosis (MS) - a chronic immune disease of the central nervous system with unpredictable, often with a progressive course. A white fatty substance that covers the axons (nerve fibers) - Most multiple sclerosis is associated with loss of myelin. The latter study involved 300 people from 51 medical centers in nine countries. All participants suffered from multiple sclerosis. Some patients received 0.3 and 0.6 mg of the drug, and the other part of the placebo. The scientists had the health of every four weeks for nine months by. The state of the brain and spinal cord Experts have found that the drug reduces the severity of symptoms of the disease by 40% in those participants who ingested 0.6 mg of the drug daily, compared with those who took a placebo. Dose of 0.3 mg had no significant effect. Only two patients were mild side effects that stopped after participants observed stopped taking the drug. According to Dr. Laura Bell, for people with MS, the development of oral medications is a very good news, because the drugs must be taken regularly, and there are no difficulties in tablet form. The scientists hope that the drug will be available in all of the tests in the near future.